Skip to main content
. 2023 Jul 25;13:1197850. doi: 10.3389/fonc.2023.1197850

Table 2.

Age-specific rates, crude rates, European age-standardized rates, and incidence sex ratios of all the leukemias and leukemia subgroups by sex and age group.

Age-specific rate
Sex N <1 1–4 5–9 10–14 CR (CR 95%CI) ASRE (ASRE 95%CI) ISR
I. Leukemias, myeloproliferative diseases, and myelodysplastic diseases
Both 3,259 48.3 76.6 38.2 25.7 44.0 (42.5; 45.5) 44.1 (42.6; 45.7) 1.2
Boys 1,813 44.0 81.9 43.6 27.7 47.6 (45.4; 49.8) 47.8 (45.6; 50.0)
Girls 1,446 52.9 71.0 32.4 23.6 40.2 (38.1; 42.3) 40.3 (38.2;42.4)
Ia. Lymphoid leukemias
Both 2,445 22.3 63.5 30.2 16.0 33.0 (31.7; 34.3) 33.1 (31.8; 34.5) 1.2
Boys 1,368 19.0 68.1 34.6 17.3 35.9 (34.0; 37.8) 36.1 (34.2; 38.0)
Girls 1,077 25.8 58.6 25.6 14.6 29.9 (28.2; 31.7) 30.1 (28.3; 31.9)
Ib. Acute myeloid leukemias
Both 561 16.0 9.5 5.5 6.7 7.6 (7.0; 8.2) 7.6 (7.0; 8.2) 1.1
Boys 306 14.2 10.8 6.3 6.6 8.0 (7.1; 8.9) 8.0 (7.1; 8.9)
Girls 255 17.9 8.2 4.7 6.7 7.1 (6.2; 8.0) 7.1 (6.2; 8.0)
Ic. Chronic myeloproliferative diseases
Both 82 2.2 0.9 0.9 1.2 1.1 (0.9; 1.4) 1.1 (0.9; 1.4) 1.4
Boys 49 1.7 0.9 1.0 1.7 1.3 (0.9; 1.7) 1.3 (0.9; 1.6)
Girls 33 2.8 0.9 0.8 0.7 0.9 (0.6; 1.2) 0.9 (0.6; 1.2)
Id. Myelodysplastic syndromes
Both 63 3.8 1.2 0.5 0.5 0.9 (0.6; 1.1) 0.9 (0.6; 1.1) 1.1
Boys 34 5.2 0.8 0.6 0.5 0.9 (0.6; 1.2) 0.9 (0.6; 1.2)
Girls 29 2.3 1.7 0.3 0.4 0.8 (0.5; 1.1) 0.8 (0.5; 1.1)
Ie. Unspecified and other specified leukemias
Both 108 4.0 1.6 1.1 1.4 1.5 (1.2; 1.7) 1.5 (1.2; 1.7) 1.0
Boys 56 3.9 1.3 1.1 1.6 1.5 (1.1; 1.9) 1.5 (1.1; 1.9)
Girls 52 4.1 1.7 1.0 1.3 1.5 (1.1; 1.8) 1.5 (1.1; 1.8)

CR, crude rate; ASRE, age-standardized rate using the 2013 European population; CI, confidence interval; ISR, incidence sex ratio.